Amy C. Peterson, EVP, Chief Development Officer at CytomX Therapeutics, Inc. (CTMX), sold 7,463 shares at $1.42 ($11K) on 2022-07-20, disclosed to the SEC on 2022-07-21.
Open-market sale of $11k CTMX by EVP, Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BGNE | SELL | 2018-12-19 | $4.5M | — | Filing → |
| BGNE | SELL | 2018-11-13 | $8.8M | — | Filing → |
| BGNE | SELL | 2018-08-24 | $1.3M | — | Filing → |